Insiders · VTYX

VTYX insider transactions

Ventyx Biosciences Inc. (VTYX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for VTYX

• 95d
  Senior VP, Finance Gonzales Roy returned 5,313 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 95d
  Director Subramaniam Somu returned 3,337,495 shares to the company (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 95d
  SEC Form 4 filed by Director White William Richard

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 95d
  SEC Form 4 filed by Chief Operating Officer Moore Matthew Richard

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 95d
  SEC Form 4 filed by Director Cadoret-Manier Onaiza

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 95d
  SEC Form 4 filed by Director Hulme Allison

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 95d
  Director Gujrathi Sheila returned 130,000 shares to the company (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 95d
  CHIEF SCIENTIFIC OFFICER Nuss John returned 489,481 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 95d
  CEO AND PRESIDENT Mohan Raju returned 2,372,863 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 95d
  Chief Medical Officer Forman Mark S returned 6,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 96d
  Director Subramaniam Somu disposed of 694,718 shares (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 170d
  CHIEF SCIENTIFIC OFFICER Nuss John sold $97,840 worth of shares (12,675 units at $7.72) and converted options into 34,930 shares, increasing direct ownership by 5% to 489,481 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 170d
  CEO AND PRESIDENT Mohan Raju converted options into 116,668 shares and sold $365,461 worth of shares (47,345 units at $7.72), increasing direct ownership by 3% to 2,372,863 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 200d
  Chief Medical Officer Forman Mark S was granted 3,000 shares, increasing direct ownership by 100% to 6,000 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 200d
  Senior VP, Finance Gonzales Roy was granted 1,767 shares, increasing direct ownership by 50% to 5,313 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 366d
  SEC Form 4 filed by Director Cadoret-Manier Onaiza

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 366d
  SEC Form 4 filed by Director Hulme Allison

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 366d
  SEC Form 4 filed by Director Subramaniam Somu

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 366d
  SEC Form 4 filed by Director White William Richard

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 366d
  SEC Form 4 filed by Director Gujrathi Sheila

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 387d
  Senior VP, Finance Gonzales Roy was granted 1,750 shares, increasing direct ownership by 97% to 3,546 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 387d
  Chief Medical Officer Forman Mark S was granted 3,000 shares (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 430d
  CHIEF SCIENTIFIC OFFICER Nuss John sold $2,019 worth of shares (1,887 units at $1.07), decreasing direct ownership by 0.40% to 467,226 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 432d
  CEO AND PRESIDENT Mohan Raju converted options into 11,844 shares, increasing direct ownership by 0.52% to 2,303,540 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 432d
  CHIEF SCIENTIFIC OFFICER Nuss John converted options into 4,531 shares, increasing direct ownership by 0.98% to 469,113 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 432d
  Director Subramaniam Somu disposed of 1,335,450 shares (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 452d
  Director Subramaniam Somu disposed of 1,735,306 shares (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 520d
  SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Nuss John

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 520d
  SEC Form 4 filed by CEO AND PRESIDENT Mohan Raju

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 520d
  SEC Form 4 filed by Chief Operating Officer Moore Matthew Richard

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 520d
  SEC Form 4 filed by Senior VP, Finance Gonzales Roy

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 520d
  SEC Form 4 filed by Chief Medical Officer Forman Mark S

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 524d
  CHIEF SCIENTIFIC OFFICER Nuss John sold $49,841 worth of shares (21,119 units at $2.36), decreasing direct ownership by 4% to 464,582 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 528d
  Director Gujrathi Sheila bought $300,573 worth of shares (130,000 units at $2.31) (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 535d
  CHIEF SCIENTIFIC OFFICER Nuss John sold $29,682 worth of shares (13,161 units at $2.26) and converted options into 34,930 shares, increasing direct ownership by 5% to 485,701 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 535d
  CEO AND PRESIDENT Mohan Raju converted options into 116,668 shares, increasing direct ownership by 5% to 2,291,696 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 543d
  CHIEF SCIENTIFIC OFFICER Nuss John exercised 198,934 shares at a strike of $0.20, increasing direct ownership by 75% to 463,932 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 559d
  CEO AND PRESIDENT Mohan Raju bought $959,889 worth of shares (500,000 units at $1.92), increasing direct ownership by 30% to 2,175,028 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 636d
  New insider Gonzales Roy claimed ownership of 743 shares (SEC Form 3)

  3 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 663d
  SEC Form 4 filed by Chief Medical Officer Forman Mark S

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 663d
  SEC Form 3 filed by new insider Forman Mark S

  3 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 711d
  Large owner Nsv Partners Iii Lp disposed of 641,327 shares (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 711d
  Director Subramaniam Somu disposed of 641,327 shares (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 726d
  CEO AND PRESIDENT Mohan Raju exercised 96,778 shares at a strike of $0.20, increasing direct ownership by 6% to 1,675,028 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 730d
  SEC Form 4 filed by White William Richard

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 730d
  SEC Form 4 filed by Cadoret-Manier Onaiza

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 730d
  SEC Form 4 filed by Gujrathi Sheila

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 730d
  SEC Form 4 filed by Hulme Allison

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 730d
  SEC Form 4 filed by Subramaniam Somu

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 751d
  SEC Form 4 filed by Moore Matthew Richard

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 751d
  SEC Form 3 filed by new insider Moore Matthew Richard

  3 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 782d
  Subramaniam Somu disposed of 695,339 shares (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 782d
  Nsv Partners Iii Lp disposed of 695,339 shares (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 795d
  Krueger Christopher W sold $8,921 worth of shares (1,651 units at $5.40), decreasing direct ownership by 0.58% to 284,999 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 795d
  Nuss John sold $8,921 worth of shares (1,651 units at $5.40), decreasing direct ownership by 0.62% to 264,998 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 795d
  Mohan Raju sold $23,299 worth of shares (4,312 units at $5.40), decreasing direct ownership by 0.27% to 1,578,250 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 795d
  Auster Martin sold $7,592 worth of shares (1,405 units at $5.40), decreasing direct ownership by 5% to 24,303 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 800d
  Krueger Christopher W converted options into 4,531 shares, increasing direct ownership by 2% to 286,650 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 800d
  Auster Martin converted options into 4,531 shares, increasing direct ownership by 21% to 25,708 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)
• 800d
  Mohan Raju converted options into 11,843 shares, increasing direct ownership by 0.75% to 1,582,562 units (SEC Form 4)

  4 - Ventyx Biosciences, Inc. (0001851194) (Issuer)